These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32892326)

  • 1. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
    Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
    Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
    J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
    Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
    Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of polysubstance exposure on neonatal outcomes for infants with intrauterine opioid exposure.
    McDaniel CE; Test M; Deodhar P; Jennings R; Bove J; Carlin K
    J Perinatol; 2020 Oct; 40(10):1489-1496. PubMed ID: 32641774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
    Baldo BA
    Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
    Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
    Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
    Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
    Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.
    Sutter MB; Watson H; Yonke N; Weitzen S; Leeman L
    BMC Pediatr; 2022 Jun; 22(1):345. PubMed ID: 35705944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome.
    MacMillan KDL; Morrison TM; Melvin P; Diop H; Gupta M; Wachman EM
    J Pediatr; 2022 Jun; 245():47-55. PubMed ID: 35131283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
    Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
    Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
    Velez ML; Jordan C; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial.
    Devlin LA; Hu Z; Merhar SL; Ounpraseuth ST; Simon AE; Lee JY; Das A; Crawford MM; Greenberg RG; Smith PB; Higgins RD; Walsh MC; Rice W; Paul DA; Maxwell JR; Fung CM; Wright T; Ross J; McAllister JM; Crowley M; Shaikh SK; Christ L; Brown J; Riccio J; Wong Ramsey K; Braswell EF; Tucker L; McAlmon K; Dummula K; Weiner J; White JR; Newman S; Snowden JN; Young LW;
    JAMA Pediatr; 2024 Jun; 178(6):525-532. PubMed ID: 38619854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poverty and Excess Length of Hospital Stay in Neonatal Opioid Withdrawal Syndrome.
    Vesoulis ZA; Lust CE; Cohlan BA; Liao SM; Mathur AM
    J Addict Med; 2020; 14(2):113-118. PubMed ID: 31149915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
    J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women's Prison Facility, 2016-2019.
    Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto TM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE
    J Addict Med; 2023 Sep-Oct 01; 17(5):587-591. PubMed ID: 37788614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Might Maternal Poverty Impact the Course of Neonatal Opioid Withdrawal Syndrome?
    Wachman EM
    J Addict Med; 2020; 14(2):93-94. PubMed ID: 31149916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.